Pre-market Hot Trades in US Stocks

Vogenx is up 15.02% in pre-market trading. Based on recent key news:

1. On August 15, Vogenx went public on NASDAQ with an offering price of $13, raising $81.25 million. After the listing, the stock price rose to $14.78, an increase of 4.9% from the offering price, with a market capitalization reaching $200 million. This event attracted market attention and drove the stock price up.

2. On August 15, Vogenx focuses on developing therapies for diseases related to metabolic dysfunction, with its main candidate product being mizagliflozin, which has received global licensing. The potential of this product has attracted investor interest, further pushing the stock price up. The biotechnology sector has been active recently, with significant capital inflows.

Credo Tech is up 3.12% in pre-market trading. There has been no significant news recently; trading is active, and capital flows are evident. Considering sector and industry trends, this stock shows significant volatility, and specific reasons need further observation. no_news

Top Gainers in Pre-market US Stocks

IP Strategy is up 178.66% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, this stock shows significant volatility, and specific reasons need further observation.

INVO Fertility is up 162.45%. Based on recent key news:

1. On August 17, MDxHealth SA (NASDAQ:MDXH) is down 14.7% to $0.69 in pre-market trading, after rising 75% on Friday. MDxHealth reported second-quarter sales that exceeded expectations last week and confirmed its sales guidance for fiscal year 2026 is above expectations.

2. On August 17, Creative Global Technology Holdings Ltd (NASDAQ:CGTL) is down 14.3% to $3.78 in pre-market trading, after rising 20% on Friday.

3. On August 17, Gauzy Ltd (NASDAQ:GAUZ) is down 11.2% to $0.37 in pre-market trading, after falling over 12% on Friday. Market volatility is significant, and macroeconomic dynamics need to be monitored.

UCL is up 57.81% in pre-market trading. Based on recent key news:

1. On August 17, UCL's board approved a stock repurchase plan allowing the company to repurchase up to $2 million of Class A common stock before December 31, 2027. This move aims to utilize existing cash balances for repurchases, potentially for employee stock ownership plans or cancellations. This news drove the stock price up approximately 68% in pre-market trading.

2. On August 14, UCL expects to report a 3.2% year-over-year revenue increase to $20 million in its quarterly earnings report scheduled for August 18. Analysts expect a loss of $0.05 per share, with a rating of "Buy," which has enhanced market confidence in the company's performance On August 17th, Youke Lian's leading position in the global mobile data traffic sharing industry and the announcement of its stock repurchase plan further enhanced investors' expectations for the company's future development. Changes in industry policies affect the data service market